BACKGROUND: @entity10516 is an uncommon chronic inflammatory breast condition that is characterized by @entity32 . @entity10516 presents a challenging clinical scenario, because it can mimic @entity189 . The etiology and optimal treatment remain unclear. We report our experience with @entity10516 @entity1 who presented to our clinic within the past 2  years and describe their response to our treatment modalities. METHODS: Our clinic records were reviewed for the diagnosis of @entity10516 . Charts were used to collect clinical data, @entity1 were reinter viewed, and physicians completed detailed reports on their management of these cases. All cases were diagnosed with @entity10516 based on histological findings and by ruling out other etiologies. RESULTS: Twenty-four @entity1 were identified. The mean age was 34 years. Fifty-three percent of our @entity1 emigrated from Mexico. Most @entity1 were treated with @entity229 and/or @entity1499 with overall response rate greater than 80  %. Cases that failed to improve were treated with other modalities, including antituberculosis drugs. CONCLUSIONS: @entity10516 remains a difficult entity to diagnose and to treat. The clinical course of @entity1 often is prolonged. Exclusion of other causes of granulomatous conditions is essential before initiating anti-inflammatory treatment.

XXXX : a new york public hospital experience.

@entity1 :: ('9606', 'Species') :: ['patients'] @entity32 :: ('MESH:D007249', 'Disease') :: ['granulomatous inflammation'] @entity10516 :: ('MESH:D058890', 'Disease') :: ['granulomatous mastitis', 'Granulomatous mastitis'] @entity229 :: ('MESH:D011241', 'Chemical') :: ['prednisone'] @entity189 :: ('MESH:D002277', 'Disease') :: ['carcinoma'] @entity1499 :: ('MESH:D008727', 'Chemical') :: ['methotrexate']
@entity10516 :: (MESH:D058890,Disease) :: ['Granulomatous mastitis']
